大麻使用障碍患者初次全膝关节置换术后静脉血栓栓塞、再入院率及费用更高
本研究基于全国大型数据库,将接受初次全膝关节置换术的大麻使用障碍患者与对照组按1:4匹配,发现大麻使用障碍患者90天静脉血栓栓塞、深静脉血栓和肺栓塞发生率及再入院率均显著更高,手术当日和90天费用也显著更高。
要点
- 大麻使用障碍患者初次全膝关节置换术后90天静脉血栓栓塞发生率显著更高(2.79% vs 1.78%)。
- 大麻使用障碍患者再入院率显著更高(27.03% vs 23.18%),手术当日和90天费用也显著更高。
- 术前应关注大麻使用障碍,将其纳入静脉血栓栓塞和再入院风险分层。
核心结论
- 大麻使用障碍患者初次全膝关节置换术后血栓栓塞并发症发生率、再入院率和费用均高于匹配对照组。
研究设计与样本
- 研究从全国大型数据库识别接受初次全膝关节置换术的患者,排除术前有静脉血栓栓塞、深静脉血栓、肺栓塞和凝血功能障碍者。
- 研究组与对照组按年龄、性别、合并症指数和医疗合并症以1:4比例匹配,共纳入18,388例患者(大麻使用障碍组3,680例,对照组14,708例)。
主要发现
- 大麻使用障碍组静脉血栓栓塞发生率显著更高(2.79% vs 1.78%;OR 1.58;P < .0001)。
- 大麻使用障碍组深静脉血栓发生率显著更高(2.41% vs 1.44%;OR 1.68;P < .0001)。
- 大麻使用障碍组肺栓塞发生率显著更高(0.97% vs 0.62%;P = .01)。
- 大麻使用障碍组再入院率显著更高(27.03% vs 23.18%;OR 1.22;P < .0001)。
- 大麻使用障碍组手术当日费用($14,024.88 vs $12,127.49;P < .0001)和90天费用($19,155.45 vs $16,315.00;P < .0001)均显著更高。
临床怎么用
- 对计划接受初次全膝关节置换术的患者,应评估大麻使用障碍并将其纳入静脉血栓栓塞和再入院风险分层。
- 对合并大麻使用障碍的患者,围手术期应加强血栓预防和再入院风险管理,并关注费用沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies have shown that cannabis can interfere with hematological parameters and platelet morphology. The purpose of this study is to investigate whether patients with cannabis use disorder undergoing primary total knee arthroplasty (TKA) have higher rates of (1) venous thromboemboli (VTEs); (2) readmissions; and (3) costs. METHODS: Study group patients undergoing primary TKA were identified from a large, nationwide database. Patients who had a history of VTEs, deep vein thromboses (DVTs), pulmonary emboli (PEs), and coagulopathies before their TKA were excluded. Study group patients were matched to controls in a 1:4 ratio by age, sex, a comorbidity index, and medical comorbidities. The query yielded 18,388 patients (cannabis = 3680; controls = 14,708). Outcomes analyzed included rates of 90-day VTEs, DVTs, and PEs, in addition to 90-day readmissions and costs. A P value less than .01 was considered statistically significant. RESULTS: Patients who have cannabis use disorder were found to have significantly higher incidence and odds (2.79% vs 1.78%; odds ratio [OR], 1.58; P < .0001) of VTEs, DVTs (2.41% vs 1.44%; OR, 1.68; P < .0001), and PEs (0.97% vs 0.62%; P = .01). Readmissions were significantly higher (27.03% vs 23.18%; OR, 1.22; P < .0001) in patients who have cannabis use disorder. Patients with cannabis use disorder have significantly higher day of surgery ($14,024.88 vs $12,127.49; P < .0001) and 90-day costs ($19,155.45 vs $16,315.00; P < .0001). CONCLUSION: This study found that patients who have a cannabis use disorder have higher rates of thromboembolic complications, readmission rates, and costs following primary TKA compared to a matched cohort.
引用
- Vakharia RM, Sodhi N, Anis HK, et al. Patients Who Have Cannabis Use Disorder Have Higher Rates of Venous Thromboemboli, Readmission Rates, and Costs Following Primary Total Knee Arthroplasty. J Arthroplasty. 2019. PMID: 31973970. doi:10.1016/j.arth.2019.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。